FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure - FDA Press Releases

FDA approves Doptelet (avatrombopag) to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical procedure.

from Food and Drug Administration--Press Releases https://ift.tt/2rYWkmQ
via IFTTT